Cuarto Simposio Anual Latinoamericano de Choque Cardiogénico 2026
al , en Playa del Carmen, México
Addressing Cardiogenic Shock from LATAM
The Fourth Annual Cardiogenic Shock Symposium, led by TecSalud, continues to position itself as a leading academic forum in the region. This year's edition will once again bring together experts to explore the latest advances, ongoing challenges, and cutting-edge strategies in the management of cardiogenic shock and acute heart failure, fostering collaboration and innovation across Latin America.
Program
Explore two days of expert-led sessions, clinical discussions, and collaborative conversations focused on cardiogenic shock care across Latin America.
|
Session 1. The First 60 Minutes: Early Recognition and System Activation / HS Symposium |
|
| 4:00–4:08 PM |
When to Pull the Trigger: Practical Criteria for Early Shock Team Activation |
| 4:08–4:16 PM |
Recognizing the Turning Point: Clinical and Hemodynamic Clues Before Collapse |
| 4:16–4:24 PM |
Building a Winning Shock Network: Lessons from High-Performing Regional Systems |
| 4:32–4:45 PM |
Discussion |
|
Session 2. Cardiogenic Shock in Women |
|
| 5:15–5:23 PM |
Sex-Related Differences in Presentation and Outcomes |
| 5:23–5:31 PM |
Peripartum Cardiogenic Shock and Takotsubo Syndrome |
| 5:31–5:39 PM |
Mechanical Circulatory Support in Women |
| 5:39–5:47 PM |
The Need for Women’s Leadership in Cardiogenic Shock |
| 5:47–6:00 PM |
Discussion |
Session 3. AMI Shock: Beyond the Culprit Artery | |
| 8:15–8:23 AM | Contemporary Management of AMI-Related Cardiogenic Shock |
| 8:23–8:31 AM | AMI Shock with Multivessel Disease: Clinical Case |
| 8:31–8:39 AM | Debate—Pro: Culprit-Vessel-Only Revascularization Is the Way to Go |
| 8:39–8:47 AM | Debate—Con: Multivessel Revascularization |
| 8:47–9:00 AM | Discussion |
Session 4. High-Risk and Complex PCI in Cardiogenic Shock / CITIC | |
| 9:00–9:08 AM | Defining High-Risk PCI Criteria in Unstable Patients |
| 9:08–9:16 AM | Identifying Candidates for Prophylactic Mechanical Circulatory Support |
| 9:16–9:24 AM | Integrating Imaging and Physiology in Complex PCI During Shock |
| 9:24–9:32 AM | Clinical Case Discussion: High-Risk PCI in Cardiogenic Shock with Mechanical Circulatory Support |
| 9:32–9:45 AM | Discussion |
Session 5. Shock in Acute-on-Chronic Heart Failure | |
| 10:00–10:08 AM | Acute Heart Failure–Related Cardiogenic Shock: Case-Based Discussion |
| 10:08–10:16 AM | Heart Failure–Related Cardiogenic Shock Is Not AMI-Related Cardiogenic Shock |
| 10:16–10:24 AM | Left, Right, and Biventricular Failure |
| 10:24–10:32 AM | Bridge-to-Recovery vs. Bridge-to-Decision Strategies |
| 10:32–10:45 AM | Discussion |
Session 6. Myocardial Recovery | |
| 10:45–10:53 AM | Clinical Case: The First Impella 5.5 Implanted in Mexico |
| 10:53–11:01 AM | Bridge to Recovery with a Percutaneous Ventricular Assist Device: Practical Considerations |
| 11:01–11:09 AM | Axillary IABP: A Simpler Solution for Ambulation and Myocardial Recovery |
| 11:09–11:17 AM | Maximizing Myocardial Recovery After a Myocardial Infarction |
Session 7. Worst Nightmares in Cardiogenic Shock: Clinical Case-Based Discussions | |
| 11:30–11:38 AM | Recognizing Vascular Complications: Clinical Case |
| 11:38–11:46 AM | Impella-Related Complications: Clinical Case |
| 11:46–11:54 AM | ECMO-Related Complications: Clinical Case |
| 11:54 AM–12:02 PM | Tools and Skills to Treat and Minimize Complications in Cardiogenic Shock |
| 12:02–12:15 PM | Discussion |
Session 8. Pulmonary Embolism–Related Shock | |
| 12:30–12:38 PM | High Pulmonary Vascular Resistance in Pulmonary Embolism–Related Failure: The Use of Phenylephrine |
| 12:38–12:46 PM | Mechanical Thrombectomy: An Update and Debate on Mechanical vs. Systemic Thrombolysis |
| 12:46–12:54 PM | The Role of Lactate in Pulmonary Embolism: The Forgotten Biomarker |
| 12:54–1:02 PM | The HI-PEITHO Trial: An Advancement or a Setback? |
| 1:02–1:15 PM | Discussion |
Session 9. Valvular and Structural Cardiogenic Shock | |
| 1:15–1:23 PM | Aortic Regurgitation–Related Shock: Clinical Case |
| 1:23–1:31 PM | ECMO During TAVR: Institutional Experience |
| 1:31–1:39 PM | Postcardiotomy Shock in Valvular Surgery: Weaning Strategies |
| 1:39–1:47 PM | Valvular Cardiogenic Shock: Clinical Case |
Session 10. ECMO in Cardiogenic Shock | |
| 2:00–2:08 PM | VA-ECMO in Cardiogenic Shock: Unloading as a First-Line Strategy |
| 2:08–2:16 PM | ECMO Unloading Debate |
| 2:16–2:24 PM | ECPR: ECMO in Cardiac Arrest |
| 2:24–2:32 PM | ECMO in Cardiogenic Shock: Who Is Still the Best Candidate? |
Session 11. Mechanical Circulatory Support | |
| 3:00–3:08 PM | Practical Use of ECMO and ECPR in Mexico |
| 3:08–3:16 PM | Temporary Extracorporeal Mechanical Circulatory Support: Surgical Strategies in Cardiogenic Shock |
| 3:16–3:24 PM | The Role of IABP in Cardiogenic Shock: Practicality and Cost Relevance Worldwide |
| 3:24–3:32 PM | Right Ventricular Support |
Session 12. Future Horizons: Research and Innovation | |
| 3:45–3:53 PM | The Clinical Trial Landscape: Current Status and Future Directions |
| 3:53–4:01 PM | Engineering Solutions for Cardiogenic Shock: TecSalud Project 1 |
| 4:01–4:09 PM | Engineering Solutions for Cardiogenic Shock: TecSalud Project 2 |
| 4:09–4:17 PM | The Future of Cardiogenic Shock: Advances in Artificial Intelligence, Data, and Translational Research |
| 4:17–4:30 PM | Discussion |
A glimpse into last year's event
Endorsements
Registration Virtual Attendee
Open to the general public. Join the Fourth Annual Cardiogenic Shock LATAM Symposium via live stream. No registration fee required. Access will be available through our official platform. Ideal for healthcare professionals, students, and anyone interested in cardiovascular care.
$1,100.00 MX
Get your ticketsJoin Us On-Site in Playa del Carmen
A limited number of spots are still available for on-site participation at the Cardiogenic Shock LATAM Symposium 2026. For further information, please contact:
Secrets Moxché, Playa del Carmen
